Thank you for visiting Richmond University Medical Center. View our VISITOR POLICY

CURRENT EMERGENCY DEPARTMENT WAIT TIME:

844.934.2273

Chinese (Simplified)

Chinese (Traditional)

Kurdish (Kurmanji)

Myanmar (Burmese)

Scottish Gaelic

Home » About » Richmond Quality ACO

Richmond Quality ACO in Staten Island NY | RUMCSI

ACO Name and Location

Richmond Quality, LLC
355 Bard Avenue
Staten Island, NY 10310

ACO Primary Contact

Primary Contact Name	Humroy Mendez, MS
Primary Contact Phone Number	718 818-1719
Primary Contact Email Address	hmendez@rumcsi.org

Organizational Information

ACO participants:

ACO Participants	ACO Participant in Joint Venture (Enter Y or N)
Nicolette Filitis	N
Amboy Medical Practice PC	N
Neil Nepola MD	N
Richmond Medical Center	N
The Narrows Medical Group PC	N
Premier Medical Pllc	N
Leroy Hardyal, MD	N
GEORGE JOHN AYYAD PHYSICIAN PC	N
Peter Stathopoulos	N
Deepak Vadhan MD FCCP PC	N
Deborah A. Aanonsen Do Pllc	N
Frank Scafuri Iii D.O. P.C.	N

ACO governing body:

Member	Member’s Voting Power –Expressed as a percentage or number	Membership Type	ACO Participant Legal Business Name/DBA, if Applicable
Last Name	First Name	Title/Position
LaBarbera, MD	Marianne	Chairman of the Board	1	ACO Participant Representative	Amboy Medical Practice, PC
Ayyad, MD	George	Vice President	1	ACO Participant Representative	George John Ayyad,
Naing, MD	Sundee	Vice President	1	ACO Participant Representative	Amboy Medical Practice, PC
Scafuri, MD	Frank	Secretary	1	ACO Participant Representative	Frank Scafuri III DO PC
Murray	Dave	Co-Chair Finance Committee	1	ACO Participant Representative	Richmond Medical Center
Mendez	Humroy	Co-Chair, Performance Improvement	0	ACO Participant Representative	Richmond Medical Center
Stathopoulos, MD	Peter	Co-Chair, Performance Improvement	1	ACO Participant Representative	Amboy Medical Practice, PC
Salhany, MBA, FACHE	Richard	Executive Director	1	ACO Participant Representative	Richmond Medical Center
Messina, PhD, FACHE	Daniel	Associate Executive Director	1	ACO Participant Representative	Richmond Medical Center
Carpenito, MD	Pietro	Medical Director	1	ACO Participant Representative	Richmond Medical Center
Fultz	Mary	Member	1	Member Beneficiary	N/A

Key ACO clinical and administrative leadership:

Position	Name
ACO Executive	Richard Salhany, MBA, FACHE
Medical Director	Pietro Carpenito, MD
Compliance Officer	Dale Weber, R.N.
Quality Assurance/Improvement Officer	Humroy Mendez, MS

Associated committees and committee leadership:

Committee Name	Committee Leader Name and Position
Finance Committee	Dave Murray and Marianne LaBarbera, MD, Co-Chairpersons
Performance Improvement Committee	Peter Stathopoulos, MD and Humroy Mendez, Co-Chairpersons

Types of ACO participants, or combinations of participants, that formed the ACO:

Hospital employing ACO professionals
Networks of individual practices of ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

Third Agreement Period
- Performance Year 2021, $2,494,908

Second Agreement Period
- Performance Year 2020, $3,365,658
- Performance Year 2019, $3,462,333
- Performance Year 2018, $0

First Agreement Period
- Performance Year 2017, $4,871,913
- Performance Year 2016, $3,473,744
- Performance Year 2015, $1,830,512

Shared Savings Distribution

Third Agreement Period

Performance Year 2021
- Proportion invested in infrastructure: 25 %
- Proportion invested in redesigned care processes/resources: 25%
- Proportion of distribution to ACO participants: 50%

Second Agreement Period

Performance Year 2020
- Proportion invested in infrastructure: 25 %
- Proportion invested in redesigned care processes/resources: 25%
- Proportion of distribution to ACO participants: 50%

Performance Year 2019
- Proportion invested in infrastructure: 25%
- Proportion invested in redesigned care processes/resources: 25%
- Proportion of distribution to ACO participants: 50%

Performance Year 2018
- Proportion invested in infrastructure: 25%
- Proportion invested in redesigned care processes/resources: 25%
- Proportion of distribution to ACO participants: 50%

First Agreement Period

Performance Year 2017
- Proportion invested in infrastructure: 25%
- Proportion invested in redesigned care processes/resources: 25%
- Proportion of distribution to ACO participants: 50%

Performance Year 2016
- Proportion invested in infrastructure: 25%
- Proportion invested in redesigned care processes/resources: 25%
- Proportion of distribution to ACO participants:50%

Performance Year 2015
- Proportion invested in infrastructure: 25%
- Proportion invested in redesigned care processes/resources: 25%
- Proportion of distribution to ACO participants: 50%

Quality Performance Results

2021 Quality Performance Results:

Measure #	Measure Name	Performance Rate	ACO Mean
001	Diabetes: Hemoglobin A1c (HbA1c) Poor Control²	10.17	12.46
134	Preventative Care and Screening: Screening for Depression and Follow-up Plan	92.36	74.38
236	Controlling High Blood Pressure	80.94	74.87
318	Falls: Screening for Future Fall Risk	98.20	87.03
110	Preventive Care and Screening: Influenza Immunization	83.55	80.52
226	Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention	97.92	80.97
113	Colorectal Cancer Screening	67.59	73.63
112	Breast Cancer Screening	71.45	75.11
438	Statin Therapy for the Prevention and Treatment of Cardiovascular Disease	83.77	84.24
370	Depression Remission at Twelve Months	19.23	15.50
321	CAHPS for MIPS³	N/A	N/A
479	Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups²	0.1659	0.1540
MCC1	All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions for ACOs (MCC)²	33.16	33.99

For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.

Payment Rule Waivers

Waiver for Payment for Telehealth Services:
- Our ACO clinicians provide telehealth services using the flexibilities under 42 CFR § 425.612(f) and 42 CFR § 425.613